Estrella Immunopharma, Inc. (ESLA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Estrella Immunopharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2024 | 2022 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.40x | -5.30x | -4.98x | -34.71x | -59.53x | -467.79x |
| P/B Ratio | -5.54x | 9.06x | 306.25x | -56.26x | 8.39x | 0.00x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.12x | 24.65x | 0.55x | 5.20x | 0.05x | 0.00x |
| Quick Ratio | 0.12x | 24.65x | 0.55x | 5.20x | 0.05x | 0.00x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.07x | 0.00x |
YoY = year-over-year change. Source: FMP..